Medivir to split R&D, commercial into two companies

Medivir AB (SSE:MVIR B) said it will split into two independent companies, one focused on R&D and one housing the company's commercial products. The company expects to complete the division by YE16.

In June, Medivir's board asked management to consider a split, saying a division "could be advantageous for the company's shareholders." ...